Not recruiting
Squamous cell carcinoma of head and neck
Not recruitingStudy of Pembrolizumab, Epacadostat, and Drug Combination for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Registered drugNo placebo
Study of Pembrolizumab, Epacadostat, and Drug Combination for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Registered drugNo placebo
- Disease:Squamous cell carcinoma of head and neck
- Substances:CarboplatinCetuximab+4
Countries:
Portugal
Portugal- Participants:18–64 years · 65+ years
- Substances:Carboplatin

